How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts

European Heart Journal

Volumn 27, Issue 3, 2006, Pages 323-329

  McAlister, Finlay A ^a   Tu, Jack V ^b,c   Newman, Alice ^b   Lee, Douglas S ^b   Kimber, Shane ^d   Cujec, Bibiana ^d   Armstrong, Paul W ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiac resynchronization therapy; Eligibility; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; SINUS RHYTHM;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; COHORT STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; PROSPECTIVE STUDIES; SPIRONOLACTONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 30744466392     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi446     Document Type: Article

References (33)

1. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W. Cardiac resynchronization therapy in patients with symptomatic heart failure: a systematic review. Ann Intern Med 2004;141:381-390.
2. Cleland JGF, Daubert JC, Erdmeann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L for the CARE-HF Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
3. Willerson JT, Kereiakes DJ. Cardiac resynchronization therapy. Helpful now in selected patients with CHF. Circulation 2004;109:308-309.
4. Shen AYJ, Wang XZ, Doris J, Moore N. Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. Am J Cardiol 2004;94:673-676.
5. Gupta SN, Jose VJ, Chandy ST. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy? Indian Heart J 2003;55:619-623.
6. Guyomar Y, Houchaymi Z, Graux P, Heuls S, Rihani R, Cornaert P, Moulin C, Grimaud JP, Dutoit A. Indications for multisite pacing in patients with heart failure. Am J Cardiol 2001;88:688-690.
7. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-1250.
8. De Sutter J, De Bondt P, Van de Wiele C, Fonteyne W, Dierckx R, Clement D, Taverni R. Prevalence of potential candidates for biventricular pacing among patients with known coronary artery disease: a prospective registry from a single center. Pacing Clin Electrophysiol 2000;23:1718-1721.
9. Werling C, Weisse U, Siemon G, Kiessling AH, Rameken M, Schwacke H, Saggau W, Senges J, Seidl K. Biventricular pacing in patients with ICD: how many patients are possible candidates? Thorac Cardiovasc Surg 2002;50:67-70.
10. Grimm W, Sharkova J, Funck R, Maisch B. How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy? Pacing Clin Electrophysiol 2003;26:155-157.
11. Pedone C, Grigioni F, Boriani G, Lafiego C, Vassallo PL, Potena L, Coccolo F, Magnani G, Biffi M, Martignani C, Frabetti L, Zannoli R, Magelli C, Branzi A. Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation. Am J Cardiol 2004;93:371-373.
12. Cleland JGF, Khand A, Clark AC. The heart failure epidemic: exactly how big is it? Eur Heart J 2001;22:623-626.
13. Cleland JGF, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631-1639.
14. McAlister FA, Teo KK, Taher M, Montague TJ, Humen D, Cheung L, Kiaii M, Yim R, Armstrong PW. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999;138:87-94.
15. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA 2003;290:2581-2587.
16. Tandon P, McAlister FA, Tsuyuki RT, Hervas-Malo M, Dupuit R, Ezekowitz J, Cujec B, Armstrong PW. The use of beta-blockers in a heart function clinic: dosing, tolerance, and outcomes. Arch Intern Med 2004;164:769-774.
17. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
18. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert J-C on behalf of the MUSTIC study group. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.
19. Garrigue S, Bordachar P, Reuter S, Jais P, Kobeissi A, Gaggini G, Haissaguerre M, Clementy J. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart 2002;87:529-534.
20. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K for the MIRACLE ICD Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
21. Curtis AB, Abraham WT, Chen PS, Ellenbogen KA, Epstein AE, Friedman PA, Hohnloser SH, Kanter RJ, Stevenson WG. Highlights of Heart Rhythm 2004, the Annual Scientific Sessions of the Heart Rhythm Society: May 19 to 22, 2004, in San Francisco, California. J Am Coll Cardiol 2004;44:1550-1556.
22. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
23. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet 2003;362:147-158.
24. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463.
25. Stewart S, Demers C, Murdoch DR, McIntyre K, MacLeod ME, Kendrick S, Capewell S, McMurray JJ. Substantial between-hospital variation in outcome following first emergency admission for heart failure. Eur Heart J 2002;23:650-657.
26. Philbin EF, Rocco TA, Lindenmuth NW, Ulrich K, Jenkins PL. Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 1999;107:549-555.
27. Nichol G, Kaul P, Huszti E, Bridges JFP. Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med 2004;141:343-351.
28. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: Caveat Medicus! J Am Coll Cardiol 2004;43:1145-1148.
29. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM for the COMPANION Investigators. Effect of cardiac resynchronization therapy with and without an implantable defibrillator on morbidity and mortality in advanced chronic heart failure: The COMPANION Trial. N Engl J Med 2004;350:2140-2150.
30. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-1459.
31. Fantoni C, Kawabata M, Massaro R, Regoli F, Raffa S, Arora V, Salerno-Uriarte JA, Klein HU, Auricchio A. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electro-anatomic mapping system. J Cardiovasc Electrophysiol 2005;16:112-119.
32. Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001;358:439-444.
33. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, Sandberg KR, McCullough PA. Congestive heart failure and QRS duration. Establishing prognosis study. Chest 2002;122:528-534.